Table 2. Clinical characteristics according to simultaneous presence of H. pylori and IL-1 polymorphisms.
| H. pylori with IL-1 polymorphisms (n = 70) | Others (n = 134) (Without coincidence of H. pylori and IL-1 polymorphisms) | P value | |
|---|---|---|---|
| Male (%) | 51 (72.9) | 88 (65.7) | 0.344 |
| Age (years) | 68.7 ± 9.8 | 70.0 ± 11.5 | 0.414 |
| BMI (kg/m2) | 24.1 ± 3.9 | 23.6 ± 3.6 | 0.426 |
| Abdominal Circumference (cm) | 87.5 ± 9.4 | 87.4 ± 8.9 | 0.968 |
| Diabetes (%) | 32 (45.7) | 54 (40.3) | 0.460 |
| Hypertension (%) | 55 (78.6) | 99 (73.9) | 0.497 |
| Dyslipidemia (%) | 50 (71.4) | 99 (73.9) | 0.741 |
| Current smoking (%) | 18 (25.7) | 32 (23.9) | 0.864 |
| Family history (%) | 21 (30.0) | 32 (23.9) | 0.401 |
| CKD (%) | 17 (24.3) | 45 (33.6) | 0.201 |
| Previous MI (%) | 3 (4.3) | 5 (3.7) | 1.0 |
| Previous stroke (%) | 7 (10.0) | 12 (9.0) | 0.804 |
| PAD (%) | 5 (7.1) | 10 (7.5) | 1.0 |
| hs-CRP (mg/dl) | 0.06 (0.04–0.12) | 0.03 (0.02–0.05) | < 0.001 |
| STEMI (%) | 44 (62.9) | 59 (44.0) | 0.012 |
Abbreviations: H. pylori, Helicobacter pylori; IL-1, interleukin-1; BMI, body mass index; CKD, chronic kidney disease; MI, myocardial infarction; PAD, peripheral arterial disease; hs-CRP, high-sensitivity C-reactive protein; STEMI, ST-segment elevation myocardial infarction